Anuncia Announces Successful First-in-Human Use of the Alivio ReFlow™ Ventricular System for Treatment of Hydrocephalus ›
Alcyone Lifesciences Receives FDA Clearance for the Alivio System for the Treatment of Hydrocephalus ›
Alcyone Lifesciences Completes Spin-Off of Hydrocephalus Business, Anuncia ›
Discover the technology behind our patent-protected ReFlow™* Ventricular system, and find out what the future holds for Anuncia.
June 25th, 2019 – June 29th, 2019
Canary Islands
September 13th, 2019 – September 16th, 2019
Vancouver, CA
October 6th, 2019
Medford, MA
June 25th, 2020 – June 27th, 2020
Houston, TX
The views expressed in this video are those of Joseph R. Madsen, MD and do not necessarily reflect the views of Anuncia, our partners, collaborators, representatives, or subsidiaries.